BOCA RATON, Fla.--(BUSINESS WIRE)--Aug. 29, 2006--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has announced that Dorothy Bray, Ph.D., representing ImmunoClin Ltd, has joined the ReceptoPharm Scientific Advisory Board. Dr. Bray served as the Director of HIV Clinical Development at GlaxoSmithKline (GSK) with global responsibility for their clinical trials program. GSK is currently the largest provider of HIV antiretroviral drugs with an estimated 40% global market share.
